SFE Investment Counsel Sells 239 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

SFE Investment Counsel trimmed its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 9.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,361 shares of the financial services provider’s stock after selling 239 shares during the period. SFE Investment Counsel’s holdings in iShares Biotechnology ETF were worth $312,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Valeo Financial Advisors LLC bought a new position in shares of iShares Biotechnology ETF during the third quarter worth about $206,000. Prism Advisors Inc. acquired a new stake in iShares Biotechnology ETF during the 3rd quarter worth about $206,000. SeaCrest Wealth Management LLC increased its stake in shares of iShares Biotechnology ETF by 203.7% in the 3rd quarter. SeaCrest Wealth Management LLC now owns 10,213 shares of the financial services provider’s stock valued at $1,487,000 after acquiring an additional 6,850 shares in the last quarter. SPC Financial Inc. grew its stake in shares of iShares Biotechnology ETF by 2.4% in the 3rd quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after buying an additional 75 shares during the period. Finally, Good Life Advisors LLC increased its stake in iShares Biotechnology ETF by 59.4% during the 3rd quarter. Good Life Advisors LLC now owns 2,666 shares of the financial services provider’s stock valued at $388,000 after purchasing an additional 993 shares in the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $135.47 on Thursday. iShares Biotechnology ETF has a 1-year low of $123.60 and a 1-year high of $150.57. The stock’s fifty day simple moving average is $135.88 and its two-hundred day simple moving average is $141.13.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.